OHSS, the IVF Side-Effect Making Women's Fertility Journeys 'Agony'
By Sophie Wilkinson,
The Huffington Post UK
| 02. 08. 2020
“I was in excruciating pain, I was bloated and felt really sick. The doctor had said I’d be able to go about my normal business but I missed work, I couldn’t do anything and I had to stay in bed for six days.”
Carol*, 39, from London, is an IVF success story. On her second cycle, she became pregnant and she now has a joyful toddler. But during her first cycle, as well as the invasive trips to the doctors and grimacing through the daily self-administered progesterone injections, she developed what her doctors called a “borderline” ovarian hyper stimulation syndrome (OHSS).
The symptoms Carol experienced are some of the many side-effects of OHSS, which can range from nausea and vomiting to severe bloating and blood clots. In the worst cases, OHSS can be fatal – according to government records, it has killed two British women in the past 15 years.
Statistics from the Human Embryology and Fertility Agency (HFEA), the fertility industry regulator that is required to record all incidences of OHSS, suggest a third of women undergoing IVF will...
Related Articles
Flag of South Africa; design by Frederick Brownell,
image by WikimediaCommons users.
Public domain, via Wikimedia Commons
What is the legal status of heritable human genome editing (HHGE)? In 2020, a comprehensive policy analysis by Baylis, Darnovsky, Hasson, and Krahn documented that more than 70 countries and an international treaty prohibit it, and that no country explicitly permits it. Policies in some countries were non-existent, ambiguous, or subject to possible amendment, but the general rule remained, even after one...
By Bernice Lottering, Gene Online | 11.08.2024
South Africa’s updated health-research ethics guidelines, which now include heritable human genome editing, have sparked concern among scientists. The revisions, made in May but only recently gaining attention, outline protocols for modifying genetic material in sperm, eggs, or embryos—changes that...
By Jim Thomas, Scan the Horizon | 11.19.2024
It’s the wee hours of 2nd November 2024 in Cali, Colombia. In a large UN negotiating hall Colombian Environment Minister Susana Muhamed has slammed down the gavel on a decision that should send a jolt through the AI policy world. ...
By Ned Pagliarulo, BioPharmaDive | 11.05.2024
A medicine built around a more precise form of CRISPR gene editing appeared to work as designed in its first clinical trial test, developer Beam Therapeutics said Tuesday. But the death of a trial participant could renew concerns about an older...